Brown Brothers Harriman & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.96K	Buy	+219	New	+$1.96K	﹤0.01%	1415
2023 Q2	–	Sell	-13,000	Closed	-$108K	–	1227
2023 Q1	$108K	Buy	+13,000	New	+$108K	﹤0.01%	592